Clinical trial
SARCOTHAL. Thalidomide in Skin Sarcoidosis
NCT00305552 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00305552 |
|---|---|
| Title | SARCOTHAL. Thalidomide in Skin Sarcoidosis |
| Official title | Randomized Controlled Trial of Thalidomide vs Placebo in Skin Sarcoidosis |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sarcoidosis |
| Intervention type | Drug |
| Interventions | THALIDOMIDE |
| Enrollment | 40 |
| Start date | Feb 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Mar 22, 2006 |
| Last update posted | May 2, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: